Home/Pipeline/Acellular Tissue Engineered Vessels (ATEV)

Acellular Tissue Engineered Vessels (ATEV)

Neonatal vascular access/repair (assumed)

Pre-clinicalActive

Key Facts

Indication
Neonatal vascular access/repair (assumed)
Phase
Pre-clinical
Status
Active
Company

About Ony Biotech

Founded in 1985 and based in Amherst, New York, ONY Biotech is a commercial-stage biotech specializing in neonatal respiratory care. Its core business is built on the FDA-approved surfactant Infasurf®, which has been a standard of care since 1998. The company is actively expanding its portfolio through clinical development of non-invasive surfactant delivery (InfasurfAero™) and partnerships for medical devices like the AerVia® Neonatal Airway, aiming to solidify its position as a leader in neonatology therapeutics and devices.

View full company profile